Literature DB >> 7489840

Visual evoked potentials in NIDDM: a longitudinal study.

G Moreo1, E Mariani, G Pizzamiglio, G B Colucci.   

Abstract

In order to assess the possible progression of neurological abnormalities over time and the value of visual evoked potential alterations in predicting stability and severity of diabetes-related optic pathway disease, a longitudinal study in non-insulin-dependent diabetic patients was performed. Neurological examination, visual evoked potentials with pattern reversal, motor and sensory nerve conduction velocities and metabolic control were studied in 18 non-insulin-dependent diabetic patients and in 35 normal control subjects at baseline and again after 4.6 +/- 0.8 years (range 4-6). At the first recording the peak P100 wave latencies were significantly delayed in the diabetic patients compared with the control subjects; signs of peripheral neuropathy were detected in five patients, clinical in three and in two there was only neurophysiological alteration without clinical signs. The second recording revealed no significant alterations of P100 latencies in patients compared with baseline, but the number with clinical signs and/or neurophysiological alterations with no clinical signs of peripheral neurological disease was increased to seven. In conclusion, we observed that visual evoked potential alterations were stable over time whereas peripheral neurological disease progressed and correlated positively with metabolic control.

Entities:  

Mesh:

Year:  1995        PMID: 7489840     DOI: 10.1007/bf00400726

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  18 in total

1.  Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy.

Authors:  A A Sima; V Nathaniel; V Bril; T A McEwen; D A Greene
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

2.  Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.

Authors:  A A Sima; A Prashar; W X Zhang; S Chakrabarti; D A Greene
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

3.  American Electroencephalographic Society. Guidelines for clinical evoked potential studies.

Authors: 
Journal:  J Clin Neurophysiol       Date:  1984-01       Impact factor: 2.177

4.  Effects of hyperglycaemia on visual evoked potentials in insulin-dependent diabetic patients.

Authors:  V Martinelli; P M Piatti; M Filippi; M Pacchioni; M R Pastore; N Canal; G Comi
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

5.  Visual evoked potentials in insulin-dependent diabetics.

Authors:  M Anastasi; M Lauricella; C Giordano; A Galluzzo
Journal:  Acta Diabetol Lat       Date:  1985 Oct-Dec

6.  Evaluation of central nervous conduction by visual evoked potentials in insulin-dependent diabetic children. Metabolic and clinical correlations.

Authors:  G Comi; V Martinelli; G Galardi; S Medaglini; L Beccaria; F Meschi; L Rosti; N Bressani; G Chiumello
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

7.  Visual evoked responses in diabetes.

Authors:  K Puvanendran; G Devathasan; P K Wong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-07       Impact factor: 10.154

8.  Neuropsychological findings in diabetes mellitus.

Authors:  J A Skenazy; E D Bigler
Journal:  J Clin Psychol       Date:  1984-01

9.  A longitudinal study of multimodal evoked potentials in diabetes mellitus.

Authors:  G Pozzessere; P A Rizzo; E Valle; M A Mollica; L Sanarelli; S Morano; P Pietravalle; U Di Mario; C Morocutti
Journal:  Diabetes Res       Date:  1989-01

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  4 in total

1.  Protective Effects of Adeno-associated Virus Mediated Brain-derived Neurotrophic Factor Expression on Retinal Ganglion Cells in Diabetic Rats.

Authors:  Yan Gong; Zhan-Ping Chang; Ruo-Tong Ren; Shi-Hui Wei; Huan-Fen Zhou; Xiao-Fei Chen; Bao-Ke Hou; Xin Jin; Mao-Nian Zhang
Journal:  Cell Mol Neurobiol       Date:  2012-02-02       Impact factor: 5.046

2.  Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy.

Authors:  J M Lopes de Faria; H Russ; V P Costa
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

3.  Diabetic Retinopathy Analysis.

Authors:  R Sivakumar; G Ravindran; M Muthayya; S Lakshminarayanan; C U Velmurughendran
Journal:  J Biomed Biotechnol       Date:  2005

4.  Pattern Visual Evoked Potentials in Patients with Type II Diabetes Mellitus.

Authors:  Javad Heravian; Akram Ehyaei; Nasser Shoeibi; Abbass Azimi; Hadi Ostadi-Moghaddam; Abbas-Ali Yekta; Mohamad Javad Khoshsima; Habbibolah Esmaily
Journal:  J Ophthalmic Vis Res       Date:  2012-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.